Journal Article Summary
The article investigates the risk of lactic acidosis associated with Imeglimin compared to Metformin, a common medication for type 2 diabetes (T2D). Lactic acidosis is a rare but serious condition that can occur with Metformin, particularly in patients with certain risk factors like kidney issues. As the prevalence of T2D continues to rise globally, understanding the safety profiles of diabetes medications is crucial for patient care, especially for those at higher risk of complications.
In the study, researchers used animal models to compare the effects of Imeglimin and Metformin on lactate levels and blood pH, which are indicators of lactic acidosis. They found that Metformin significantly increased lactate levels and decreased blood pH in both dogs undergoing surgery and rats with kidney failure, leading to lactic acidosis and even fatalities at higher doses. In contrast, Imeglimin did not cause any significant changes in lactate levels or pH, indicating a lower risk of lactic acidosis, even at high doses.
The study has limitations, including its reliance on animal models, which may not fully replicate human responses. While the findings suggest that Imeglimin may be safer than Metformin regarding lactic acidosis risk, patients should still consult healthcare professionals about their specific conditions and treatment options. It's essential for individuals with diabetes, especially those with kidney issues or other risk factors, to discuss the potential benefits and risks of their medications with their doctors.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Theurey Pierre, Vial Guillaume, Fontaine Eric, Monternier Pierre‐Axel, Fouqueray Pascale, Bolze Sébastien, Moller David E., Hallakou‐Bozec Sophie. Reduced lactic acidosis risk with Imeglimin: Comparison with Metformin. Physiological Reports 2022. DOI: 10.14814/phy2.15151. PMID: 35274817. PMCID: PMC8915386.
Featured Pill Pals Product
Metformin 500 mg Immediate Release Tablets --- Ascend Pharma --- Generic for Glucophage
Metformin 500 mg Immediate Release Tablets — Ascend Pharma — Generic for Glucophage is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
